Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Cornerstone Laying Ceremony Held for the New Israel Center of Advanced Nuclear Medicine and Radiopharmacy at Sheba

Nuclear Medicine and Radiopharmacy at Sheba
The new facility is expected to make Sheba one of the most advanced global centers for nuclear medicine.

A cornerstone for the Israel Center of Advanced Nuclear Medicine and Radiopharmacy has been laid during a ceremony held at Sheba Medical Center. The new facility is expected to make Sheba one of the most advanced global centers for nuclear medicine, imaging and radiopharmacy.

Along with state-of-the-art diagnostic imaging devices, and a large complex for innovative radioactive treatments, the new center will also feature a cyclotron – the largest and most advanced in Israel – that will allow for more accurate and rapid cancer diagnosis and treatments. With the help of the cyclotron, Sheba Medical Center will be able to develop and produce new tracers to help diagnose maladies such as heart disease, inflammatory ailments, and Alzheimer’s, as well as to produce innovative medications and treatments for local and global use.

“The establishment of the new center is a revolution in the diagnosis and treatment of cancer and other diseases,” said Prof. Yitshak Kreiss, Director General of Sheba Medical Center, who added: “Today, we took another giant step in establishing Israel’s City of Health and implementing a new vision for patient care at Sheba Medical Center.” As Dr. Liran Domachevsky, Director of the Institute of Nuclear Medicine at Sheba Medical Center, explains: “The new center will provide advanced and better treatment, and will promote the production and development of new materials that will affect the way medicine will look in the future.”


Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More